Jones Trading Maintains Buy on Relay Therapeutics, Raises Price Target to $31
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Jones Trading analyst Boris Peaker maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price target from $20 to $31.
Jones Trading analyst Boris Peaker maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price target from $20 to $31.